---
title: "Beigene: Q2 Global Total Revenue Reaches $1.7 Billion, Up 30% Year-over-Year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294947219.md"
description: "Beigene's global total revenue in the second quarter reached $1.7 billion, a 30% year-over-year increase. The company raised its full-year 2026 total revenue guidance to $6.6–$6.8 billion and expects GAAP and Non-GAAP operating profits to be in the ranges of $1.0–$1.1 billion and $1.7–$1.8 billion, respectively"
datetime: "2026-08-05T10:11:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294947219.md)
  - [en](https://longbridge.com/en/news/294947219.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294947219.md)
---

# Beigene: Q2 Global Total Revenue Reaches $1.7 Billion, Up 30% Year-over-Year

Beigene: In the second quarter, global total revenue reached $1.7 billion, up 30% year-over-year; GAAP diluted earnings per American Depositary Share (ADS) were $2.05, and Non-GAAP diluted earnings per ADS were $3.84. The full-year 2026 total revenue guidance was raised to $6.6–$6.8 billion; GAAP operating profit is expected to be $1.0–$1.1 billion, and Non-GAAP operating profit is expected to be $1.7–$1.8 billion.

Risk Warning and Disclaimer

The market involves risks, and investment should be made with caution. This article does not constitute personal investment advice, nor does it take into account the specific investment objectives, financial status, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment decisions made based on this content are the sole responsibility of the investor.

### Related Stocks

- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)

## Related News & Research

- [BeOne Medicines publishes Q2 clinical trials portfolio presentation detailing pipeline and study updates](https://longbridge.com/en/news/294973584.md)
- [Insider Selling: BeOne Medicines (NASDAQ:ONC) SVP Sells 1,044 Shares of Stock](https://longbridge.com/en/news/294789861.md)
- [EPAM Q2 GAAP diluted EPS rises 26.3% to $1.97; revenue increases 4.5% to $1.42 billion](https://longbridge.com/en/news/295088155.md)
- [Indivior Q2 FY26 GAAP net income rises to $122 million; revenue increases 14% to $343 million YoY](https://longbridge.com/en/news/294679226.md)
- [ISG Q2 FY26 GAAP EPS rises 75% to $0.07; revenue increases 6.4% to $65.5 million](https://longbridge.com/en/news/295016813.md)